Cargando…

Circulating soluble Fas levels and risk of ovarian cancer

BACKGROUND: Dysregulation of apoptosis, specifically overexpression of soluble Fas (sFas), has been proposed to play a role in the development of ovarian cancer. The main objective of the present study was to evaluate serum sFas as a potential biomarker of ovarian cancer risk. METHODS: The associati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akhmedkhanov, Arslan, Lundin, Eva, Guller, Seth, Lukanova, Annekatrin, Micheli, Andrea, Ma, Yuehong, Afanasyeva, Yelena, Zeleniuch-Jacquotte, Anne, Krogh, Vittorio, Lenner, Per, Muti, Paola, Rinaldi, Sabina, Kaaks, Rudolf, Berrino, Franco, Hallmans, Göran, Toniolo, Paolo
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC317312/ https://www.ncbi.nlm.nih.gov/pubmed/14690548 http://dx.doi.org/10.1186/1471-2407-3-33

Ejemplares similares

Reliability of follicle-stimulating hormone measurements in serum
por: Arslan, Alan A, et al.
Publicado: (2003)

Postmenopausal circulating levels of 2- and 16α-hydroxyestrone and risk of endometrial cancer
por: Zeleniuch-Jacquotte, A, et al.
Publicado: (2011)

Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study
por: Scarmo, Stephanie, et al.
Publicado: (2013)

Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study
por: Zeleniuch-Jacquotte, A, et al.
Publicado: (2004)

Premenopausal serum androgens and breast cancer risk: a nested case-control study
por: Zeleniuch-Jacquotte, Anne, et al.
Publicado: (2012)

Circulating Vitamin D and Risk of Epithelial Ovarian Cancer
por: Arslan, Alan A., et al.
Publicado: (2009)

Genetic Variants in Hormone-Related Genes and Risk of Breast Cancer
por: Clendenen, Tess, et al.
Publicado: (2013)

Genetic Polymorphisms in Vitamin D Metabolism and Signaling Genes and Risk of Breast Cancer: A Nested Case-Control Study
por: Clendenen, Tess V., et al.
Publicado: (2015)

Early pregnancy sex steroids during primiparous pregnancies and maternal breast cancer: a nested case–control study in the Northern Sweden Maternity Cohort
por: Fortner, Renée T., et al.
Publicado: (2017)

Aspirin and lung cancer in women
por: Akhmedkhanov, A, et al.
Publicado: (2002)

Defining the genomic signature of the parous breast
por: Peri, Suraj, et al.
Publicado: (2012)

The challenge of measuring circulating estradiol at low concentrations
por: Toniolo, Paolo, et al.
Publicado: (2005)

Genomic signature of parity in the breast of premenopausal women
por: Santucci-Pereira, Julia, et al.
Publicado: (2019)

Serum folate, homocysteine and colorectal cancer risk in women: a nested case–control study
por: Kato, I, et al.
Publicado: (1999)

Serum Taurine and Stroke Risk in Women: A Prospective, Nested Case-Control Study
por: Wu, Fen, et al.
Publicado: (2016)

Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study
por: Zeleniuch-Jacquotte, A, et al.
Publicado: (2001)

Temporal reliability of cytokines and growth factors in EDTA plasma
por: Clendenen, Tess V, et al.
Publicado: (2010)

Circulating enterolactone and risk of breast cancer: a prospective study in New York
por: Zeleniuch-Jacquotte, A, et al.
Publicado: (2004)

A prospective study of dietary selenium intake and risk of type 2 diabetes
por: Stranges, Saverio, et al.
Publicado: (2010)

Breast cancer risk prediction in women aged 35–50 years: impact of including sex hormone concentrations in the Gail model
por: Clendenen, Tess V., et al.
Publicado: (2019)

Long-Term Exposure to Walkable Residential Neighborhoods and Risk of Obesity-Related Cancer in the New York University Women’s Health Study (NYUWHS)
por: India-Aldana, Sandra, et al.
Publicado: (2023)

Temporal reproducibility of IgG and IgM autoantibodies in serum from healthy women
por: Clendenen, T. V., et al.
Publicado: (2022)

Prognostic role of elevated mir-24-3p in breast cancer and its association with the metastatic process
por: Khodadadi-Jamayran, Alireza, et al.
Publicado: (2018)

Blood Glucose and Risk of Incident and Fatal Cancer in the Metabolic Syndrome and Cancer Project (Me-Can): Analysis of Six Prospective Cohorts
por: Stocks, Tanja, et al.
Publicado: (2009)

Maternal pregnancy hormone profiles in areas with a different incidence of breast cancer
por: Akhmedkhanov, A A, et al.
Publicado: (2000)

Endogenous sex steroids in premenopausal women and risk of breast cancer: the ORDET cohort
por: Schernhammer, Eva S, et al.
Publicado: (2013)

Low-carbohydrate, high-protein diet score and risk of incident cancer; a prospective cohort study
por: Nilsson, Lena Maria, et al.
Publicado: (2013)

Goodness-of-fit two-phase sampling designs for time-to-event outcomes: a simulation study based on New York University Women’s Health Study for breast cancer
por: Lee, Myeonggyun, et al.
Publicado: (2023)

Development of Inflammatory Angiogenesis by Local Stimulation of Fas In Vivo
por: Biancone, Luigi, et al.
Publicado: (1997)

Hormone concentrations throughout uncomplicated pregnancies: a longitudinal study
por: Schock, Helena, et al.
Publicado: (2016)

The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability
por: Henkler, Frank, et al.
Publicado: (2005)

Monitoring human lymphocytic DNA-protein cross-links as biomarkers of biologically active doses of chromate.
por: Costa, M, et al.
Publicado: (1996)

Genome-Wide DNA Methylation Profiles in Community Members Exposed to the World Trade Center Disaster
por: Arslan, Alan A., et al.
Publicado: (2020)

Anti-Mullerian hormone and endometrial cancer: a multi-cohort study
por: Fortner, Renée T, et al.
Publicado: (2017)

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
Publicado: (1996)

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2020)

Understanding the role of Fas-Fas ligand system in bone
por: Marusic, Ana, et al.
Publicado: (2012)

Differential expressions of Fas and Fas ligand in human placenta.
por: Roh, Cheong-Rae, et al.
Publicado: (2002)

Soluble Fas and the −670 Polymorphism of Fas in Lupus Nephritis
por: Bollain-y-Goytia, Juan José, et al.
Publicado: (2014)

The Fas/FasL System in Reproduction: Survival and Apoptosis
por: Mor, Gil, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_qvb55j1pmn721shh29jl4c50mf